Revolution Medicines Inc - Warrants (17/12/2026)
RVMDW
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
$1.18
81.1% downside
Current Fair Value
81.1% downsideOvervalued by 81.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | - |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $-5.95 |
| Beta | 1.41 |
| Outstanding Shares | 198,098,047 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -22.74 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 11, 2026
EPS Estimate
$-1.84
Average shareholder expectationRevenue Estimate
$2.42 M
Average shareholder expectationNext Earnings Call
Expected Date
August 12, 2026
EPS Estimate
$-1.96
Average shareholder expectationRevenue Estimate
$18.06 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About
No data